Yahoo Web Search

Search results

1. • 

     Home Phototherapy for Psoriasis: Optimizing Access

     Medscape· 9 hours ago

     Supporters of home phototherapy for patients with plaque and guttate psoriasis had plenty to cheer about at the annual meeting of the American Academy of...

2. • 

     Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief

     Verywell Health via Yahoo News· 20 hours ago

     With two kids under 2, I needed some relief. I had been through enough psoriasis treatment and had...

3. • 

     Nail Psoriasis

     Health via Yahoo News· 5 days ago

     Biopsy: Your provider might collect a biopsy (small skin sample) from the nail bed and send it to a laboratory for evaluation. Nail Psoriasis Treatment...

4. • 

     BMS reports four-year data from psoriasis treatment extension trial

     Clinical Trials Arena via Yahoo Finance· 5 days ago

     The study followed the Phase III POETYK PSO-1 and POETYK PSO-2 trials...remained consistent over the...

5. • 

     J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial

     Clinical Trials Arena via Yahoo Finance· 1 day ago

     J&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...

6. • 

     InnoCare Pharma concludes subject enrolment Phase II psoriasis trial

     Clinical Trials Arena via Yahoo Finance· 6 days ago

     InnoCare Pharma has announced the completion of subject enrolment in the Phase II clinical trial of...

7. • Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. -...

     Benzinga· 2 days ago

     ALVO, today announced the availability of SIMLANDI (adalimumab-ryvk) injection in the U.S., as an interchangeable biosimilar to Humira for the treatment of adult rheumatoid ...

8. • Ultravate side effects: What they are and how to manage them

     Healthline· 2 days ago

     Ultravate (halobetasol propionate) is a prescription drug that’s used to treat plaque psoriasis. Ultravate can cause side effects that range from mild to ...

9. • TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...

     FOX 23 News Albany· 2 days ago

     WASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...

10. • 

      Maintenance Tx With Guselkumab for UC Meets All Endpoints

      Medscape· 9 hours ago

      Guselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...